tiprankstipranks
Addex Therapeutics (DE:APE)
FRANKFURT:APE

Addex Therapeutics (APE) Stock Price & Analysis

1 Followers

APE Stock Chart & Stats

Day’s Range€0 - €0
52-Week Range€1.36 - €1.44
Previous Close€1.36
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise Value€8.73M
Total Cash (Recent Filing)$6.96M
Total Debt (Recent Filing)$373.13K
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding178,234,496
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)-0.19
Price to Sales (P/S)169.78
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.52
Enterprise Value/Gross Profit6.14
Enterprise Value/Ebitda-0.52
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

APE FAQ

What was Addex Therapeutics’s price range in the past 12 months?
Addex Therapeutics lowest stock price was €1.35 and its highest was €1.44 in the past 12 months.
    What is Addex Therapeutics’s market cap?
    Currently, no data Available
    When is Addex Therapeutics’s upcoming earnings report date?
    The company’s upcoming earnings report date is not yet available.
    How were Addex Therapeutics’s earnings last quarter?
    Currently, no data Available
    Is Addex Therapeutics overvalued?
    According to Wall Street analysts Addex Therapeutics’s price is currently same. Get more investment ideas with TipRanks Premium
      Does Addex Therapeutics pay dividends?
      Addex Therapeutics does not currently pay dividends.
      What is Addex Therapeutics’s EPS estimate?
      Addex Therapeutics’s EPS estimate for its next earnings report is not yet available.
      How many shares outstanding does Addex Therapeutics have?
      Currently, no data Available
      What happened to Addex Therapeutics’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Addex Therapeutics?
      Currently, no hedge funds are holding shares in DE:APE
      ---

      Addex Therapeutics Stock Smart Score

      N/A
      Not Ranked
      1
      2
      3
      4
      5
      6
      7
      8
      9
      10

      Company Description

      Addex Therapeutics

      Addex Therapeutics Ltd. is a biopharmaceutical company, which engages in the development of drugs for human health. It develops novel, orally available, and small molecule allosteric modulators for neurological disorders. The company was founded by Vincent Mutel, Timothy Dyer, and Mark Epping-Jordan in 2002 and is headquartered in Geneva, Switzerland.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Mymetics
      Crispr Therapeutics AG
      ADC Therapeutics
      AC Immune SA
      Popular Stocks
      ---
      What's Included in PREMIUM?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis